Role of inflammation in intrahepatic cholestasis of pregnancy

J Obstet Gynaecol Res. 2016 Mar;42(3):252-7. doi: 10.1111/jog.12902. Epub 2016 Jan 19.

Abstract

Aim: Intrahepatic cholestasis of pregnancy (ICP), the most common liver disease in pregnancy, is characterized by elevated serum total bile acid and/or transaminase concentration, and pruritus. Interleukin-6 (IL-6) is a key regulator of the immune response, hematopoiesis and inflammation. We examined both IL-6 and the frequently used inflammatory marker high-sensitivity C-reactive protein (hs-CRP) at baseline in the same study population as for the primary endpoint, in order to provide a new perspective on the pathogenesis of ICP.

Methods: In this controlled cross-sectional study 65 consecutive pregnant women with ICP (34 with mild and 31 with severe disease) and 40 healthy women with uncomplicated pregnancies (control group) were examined. IL-6 and hs-CRP were compared between the groups.

Results: While serum IL-6 was significantly higher in the mild ICP (P = 0.01) and severe ICP (P = 0.001) groups than in the control group, hs-CRP was similar between the groups.

Conclusion: Interleukin-6 may have an essential role, apart from CRP, in the pathogenesis of ICP and, also, is a more sensitive marker of inflammation.

Keywords: C-reactive protein; bile acid; hepatocellular injury; interleukin-6.

MeSH terms

  • Adult
  • C-Reactive Protein / metabolism*
  • Case-Control Studies
  • Cholestasis, Intrahepatic / blood*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Inflammation / blood*
  • Interleukin-6 / blood*
  • Pregnancy
  • Pregnancy Complications / blood*
  • Young Adult

Substances

  • IL6 protein, human
  • Interleukin-6
  • C-Reactive Protein

Supplementary concepts

  • Intrahepatic Cholestasis of Pregnancy